News & Publications
ReCare: 500 patients enrolled
ReCare: 500 patients enrolled
We are pleased […]
5-year report of the E²-RADIatE Platform
5-year report of the E²-RADIatE Platform:
Executive summary […]
Important new results from EORTC presented at ESTRO Congress 2025
Important new results from EORTC presented at ESTRO Congress 2025 […]
Publications
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort
Acute toxicity in patients with oligometastatic cancer following metastasis-directed [...]
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E²-RADIatE OligoCare study
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy [...]
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E²-RADIatE OligoCare cohort
Health-related quality of life in men with oligometastatic prostate [...]